Pronk, A. C. http://orcid.org/0000-0001-5154-2369
van Poelgeest, E. P.
Seppala, L. J.
Ploegmakers, K. J.
Stricker, B. H.
Swart, K. M. A.
van Dijk, S. C.
Oliai Araghi, S.
de Groot, L. C. P. G. M.
van Schoor, N. M.
Mathôt, R. A. A.
van der Velde, N.
Funding for this research was provided by:
Amsterdams Universiteitsfonds (3021, 3549)
Article History
Received: 19 October 2022
Accepted: 29 December 2022
First Online: 19 January 2023
Declarations
:
: KS is an employee of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related healthcare authorities and several pharmaceutical companies. The other authors have declared that no competing interest exist.
: For the B-PROOF study the Medical Ethics Committee (METC) of Wageningen University approved the study protocol [ref CitationRef removed]. The study was conducted in accordance with the Declaration of Helsinki.
: In the B-PROOF all participants gave written informed consent before entering the study.